Section
Otsuka ICU Medical recalled one lot of 0.9% sodium chloride IV bags after a customer found a potassium chloride vial inside a saline overwrap—a mix-up FDA says could cause fatal arrhythmias in vulnerable patients.
A 100% duty on patented pharmaceuticals and their ingredients starts Sept. 29 for companies outside the Annex III exemptions, while generics are carved out. Most U.S. prescriptions are generics, so here is the one call worth making before Monday.
Medicare's annual enrollment window opens Oct. 15. Fraud advisories say the calls arriving ahead of it — spoofed numbers, card requests, manufactured urgency — are the ones to hang up on.
HHS reopened compliance reviews on nine drugmaker most-favored-nation pledges as CMS began shipping Medicare open-enrollment comparison kits to seniors, inserting MFN talking points into mailed plan materials even though January pharmacy prices may still reflect 2026 bids filed before pledge details landed.
The FDA cleared an updated nirsevimab labeling and lot-release pathway for infant RSV immunization ahead of winter ordering, letting hospitals and pediatric groups place bulk cold-chain orders without waiting on ad hoc compassionate-use paperwork.
Congress ordered hospitals to publish prices so Americans could shop for care — yet the number on the website is almost never the number on the bill.
